Immuno-cloaked gene therapies

Immuno-cloaked gene therapiesImmuno-cloaked gene therapiesImmuno-cloaked gene therapies

At Crane Biosciences, we make gene therapies safe and effective by hiding them from the immune system.

Contact Us

Immuno-cloaked gene therapies

Immuno-cloaked gene therapiesImmuno-cloaked gene therapiesImmuno-cloaked gene therapies

At Crane Biosciences, we make gene therapies safe and effective by hiding them from the immune system.

Contact Us

About

Enabling better gene therapies with immuno-cloaking

Gene therapies are the Holy Grail of medicine: they could cure over 6000 diseases, affecting 1Bn people, and worth over $1.2Tn.


However, 90% of gene therapies developed today fail clinical trials and are not approved. This is because the human immune system sees them as dangerous, initiating immune reactions that harm the patient and destroy the therapy. 


At Crane Biosciences, we are building a platform to hide therapies from the immune system, preventing immune reactions and creating successful treatments. 


We call this process “immuno-cloaking.” 

Meet the team

Luca Bolondi - CEO

Luca Bolondi - CEO

Luca Bolondi - CEO

Deep-tech Engineer with business background, 2x founder, >$1.5Mn raised

Linkedin

Sujaan Das - CTO

Luca Bolondi - CEO

Luca Bolondi - CEO

PhD in Molecular Biology from the Francis Crick Institute, Marie Curie Fellow

Linkedin

Oanh Vu - CCS

Luca Bolondi - CEO

Oanh Vu - CCS

PhD in Chemistry from Vanderbilt University with focus on computational peptide design

linkedin

Our backers

Connect with us

Contact Us

Send Message

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Copyright © 2022 Crane Biosciences - All rights reserved.


This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept